<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">06885</article-id><article-id pub-id-type="doi">10.7554/eLife.06885</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Ngn1 inhibits astrogliogenesis through induction of miR-9 during neuronal fate specification</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-28738"><name><surname>Zhao</surname><given-names>Jing</given-names></name><aff><institution content-type="dept">Department of Psychiatry and Behavioral Sciences and Intellectual Development and Disabilities Research Center</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28524"><name><surname>Lin</surname><given-names>Quan</given-names></name><aff><institution content-type="dept">Stem Cell Translational Research Center</institution>, <institution>Tongji University School of  Medicine</institution>, <addr-line><named-content content-type="city">Shanghai</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28739"><name><surname>Kim</surname><given-names>Kevin J</given-names></name><aff><institution content-type="dept">Department of Psychiatry and Behavioral Sciences and Intellectual Development and Disabilities Research Center</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37788"><name><surname>Dardashti</surname><given-names>Faranak D</given-names></name><aff><institution content-type="dept">Department of Psychiatry and Behavioral Sciences and Intellectual Development and Disabilities Research Center</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-39566"><name><surname>Kim</surname><given-names>Jennifer</given-names></name><aff><institution content-type="dept">Department of Psychiatry and Behavioral Sciences and Intellectual Development and Disabilities Research Center</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-28742"><name><surname>Sun</surname><given-names>Yi</given-names></name><aff><institution content-type="dept">Stem Cell Translational Research Center</institution>, <institution>Tongji University School of  Medicine</institution>, <addr-line><named-content content-type="city">Shanghai</named-content></addr-line>, <country>China</country><email>ysun@mednet.ucla.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-2901"><name><surname>Barres</surname><given-names>Ben</given-names></name><role>Reviewing editor</role><aff><institution>Stanford School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>13</day><month>08</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e06885</elocation-id><supplementary-material><ext-link xlink:href="elife-06885-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>06</day><month>02</month><year>2015</year></date><date date-type="accepted"><day>12</day><month>08</month><year>2015</year></date></history><permissions><copyright-statement>Â© 2015, Zhao et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Zhao et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>It has been postulated that a proneural factor, neurogenin 1 (Ngn1), simultaneously activates the neurogenic program and inhibits the alternative astrogliogenic program when specifying the neuronal fate.  While Ngn1 substantially suppresses the activation of the astrogliogenic Jak-Stat pathway, the underlying molecular mechanism was unknown. Here, by employing <italic>in vivo</italic> and <italic>in vitro</italic> approaches, we report that Ngn1 binds to the promoter of a brain-enriched microRNA, miR-9, and activates its expression during neurogenesis. Subsequently, our <italic>in vitro</italic> study showed that miR-9 directly targets mRNAs of <italic>Lifr-beta</italic>, <italic>Il6st (gp130)</italic>, and <italic>Jak1</italic> to down-regulate these critical upstream components of the Jak-Stat pathway, achieving inhibition of Stat phosphorylation and consequently, suppression of astrogliogenesis. This study revealed Ngn1 modulated non-coding RNA epigenetic regulation during cell fate specifications.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and Chancellor's Animal Research Committee (ARC) protocol #2002001 of UCLA.</p></fn></fn-group></back></article>